MD (KZ), M.Sc. in Clinical Research Administration (UK). SMO MERA Clinical research team leader. 17 years of professional experience including management of more than 20 different studies, Phase I, II, III, and IV clinical trials, observational studies, and registries from local and foreign Sponsors. Experience as a part-time clinical research expert in a competent authority. Kanat has experience and knowledge of a wide range of medical interventional and observational research methodologies.

Bachelor of Pharmacy (KZ), Professional experience in coordinating international multicenter interventional trials III phase, bioequivalence studies and project management of studies from local and international sponsors. Anel has knowledge and experience on launching, management and monitoring of the local and international observational studies and registers. Development of the investigational product management system, work with electronical data capture systems (OpenClinica, EDC, RedCap, local EDCs), clinical trial management system and program for statistical analysis (R).

Medical Doctor (KZ), since December 2013, Yekaterina began working in the field of clinical trials, took a number of specialized courses on Good Clinical Practice, data management, pharmacovigilance, bioethics, etc. From December 2013 to August 2015, Yekaterina worked at JSC «Scientific Center for Anti-Infectious Drugs» as a data manager and pharmacovigilance specialist of the clinical trials department, and then as the head of the department for monitoring clinical trials and databases. From January 2016 to March 2018, Yekaterina worked at NGO “Partners in Health/Harvard Medical School” as an observational study manager/pharmacovigilance specialist of the endTB international project in Kazakhstan.

Cardiologist (MD), in 2016 completed residency in cardiology, including pediatric cardiology, at the Research Institute of Cardiology and Internal Diseases. From May 2017 to December 2023, Tatyana worked at the NGO Partners in Health/Harvard Medical School as a data entry specialist (working with the OpenClinica electronic data system and quality control of data entry), then as a Clinical Trial Monitor (ensuring the quality of study conduct) for two international Clinical Trials Phase III of the endTb and endTB-Q projects.

Bachelor of Pharmacy (KZ), MPH (UK) in Public Health. Experience as Country Pharmacist for International Phase III Clinical Trials at NGO “Partners in Health/Harvard Medical School”, including key responsibilities such as forecasting (QuanTB program), obtaining import permission for investigational and ancillary products, and customs clearance procedures. Zhanelya has skills in interaction with foreign manufacturers and distributors, regulatory documents and the e-license electronic portal. Development and implementation of investigational product management system in interventional clinical trials from drugs receiving up to their destruction. Experience with electronic data entry systems (OpenClinica and RedCap).

General practitioner, with experience in the diagnostic clinic «Healthcity». Since 2016, she has worked as a data entry specialist (primary quality control) in an observational study at the NGO «Partners for Health»/Harvard Medical School. Since 2017, experience in the position of data manager/pharmacovigilance specialist and further specialist in monitoring international multicenter clinical trial III phase endTB/endTB-Q. Has skills in developing, filling forms and data verification; reconciliation/resolving queries of the OpenClinica electronic system; management of the investigator’s file (CIF/ISF); submitting reports on pharmacovigilance to regulatory authorities and ethics committee.

PhD with a degree in Public Health. An experienced biostatistician who has a rich background in preclinical and epidemiological research. Aliya is an assistant professor of the Department of Epidemiology and teaches biostatistics and epidemiology for medical specialties. She knows various up-to-date methodologies of sample size calculation of the required number of participants in epidemiological and clinical studies. Co-author of 6 publications in international peer-reviewed journals, as well as one teaching guidance.